N-tert.-Butyl-N-methyl-chloramin | 36260-83-0

• 分子结构分类: 有机化合物
• 英文名称: N-tert.-Butyl-N-methyl-chloramin
• 英文别名: N-chloro-N,2-dimethylpropan-2-amine
• CAS: 36260-83-0
• 化学式: C₅H₁₂ClN
• 分子量: 121.61
• InChiKey: DORIYZFSMOBDRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  7
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  N-甲基-叔丁基胺 在 sodium hypochlorite 作用下， 生成 N-tert.-Butyl-N-methyl-chloramin
  参考文献：
  名称：

  Stereodynamics of N-tert-butyl-N-haloamines. Experimental and theoretical investigations of nitrogen inversion and tert-butyl rotation. Dynamical model for the rotation-inversion dichotomy in all alkylamines

  摘要：

  DOI：

  10.1021/ja00848a034

文献信息

• Mixed disulfide conjugates of thienopyridine compounds and uses thereof
  申请人：The Regents of the University of Michigan

  公开号：US10173980B2

  公开（公告）日：2019-01-08

  This invention is in the field of medicinal chemistry. In particular, the invention relates to mixed disulfide conjugates of thienopyridine compounds, and their use as therapeutics for the treatment, amelioration, and prevention of cardiovascular diseases.

  本发明属于药物化学领域。特别是，本发明涉及噻吩并吡啶化合物的混合二硫化物共轭物，以及它们作为治疗、改善和预防心血管疾病的治疗剂的用途。
• USE OF PARTICULAR POLYMERS AS CHARGE STORAGE MEANS
  申请人：SCHUBERT Ulrich

  公开号：US20170058062A1

  公开（公告）日：2017-03-02

  The present invention relates to polymers and to the use thereof in the form of active electrode material or in an electrode slurry as electrical charge storage means, the electrical charge storage means especially being secondary batteries. The secondary batteries are especially notable for high cell voltages, even when undergoing several charging and discharging cycles, and simple and scalable processing and production methods (for example by means of screen printing).
• MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF
  申请人：The Regents of the University of Michigan

  公开号：US20180155289A1

  公开（公告）日：2018-06-07

  This invention is in the field of medicinal chemistry. In particular, the invention relates to mixed disulfide conjugates of thienopyridine compounds, and their use as therapeutics for the treatment, amelioration, and prevention of cardiovascular diseases.